Topical therapy for toenail onychomycosis: an evidence-based review.
Gupta AK, Daigle D, Foley KA.
Am J Clin Dermatol · review; journal article · DOI 10.1007/s40257-014-0096-2 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för efinaconazole. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
24 träffarEfinaconazole topical solution (Jublia) for onychomycosis.
Författaruppgift saknas
Med Lett Drugs Ther · journal articleEfinaconazole 10% solution in the treatment of onychomycosis of the toenails.
Joseph WS, Vlahovic TC, Pillai R, Olin JT.
J Am Podiatr Med Assoc · meta-analysis; research support, non-u.s. gov't; journal article · DOI 10.7547/0003-0538-104.5.479Penetration of ((14)C)-Efinaconazole Topical Solution, 10%, Does Not Appear to be Influenced by Nail Polish.
Zeichner JA, Stein Gold L, Korotzer A.
J Clin Aesthet Dermatol · other; journal articleNonclinical safety assessment of Efinaconazole Solution (10%) for onychomycosis treatment.
Jo W, Glynn M, Nejishima H, Sanada H, Minowa K, Calvarese B, Senda H, Pillai R, Mutter L.
Regul Toxicol Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.yrtph.2014.07.012The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
Gupta AK, Elewski BE, Sugarman JL, Ieda C, Kawabata H, Kang R, Pillai R, Olin JT, Watanabe S.
J Drugs Dermatol · journal articleThe role of topical antifungal therapy for onychomycosis and the emergence of newer agents.
Del Rosso JQ.
J Clin Aesthet Dermatol · review-article; review; journal articleIn vitro and in vivo assessment of dermatophyte acquired resistance to efinaconazole, a novel triazole antifungal.
Iwata A, Watanabe Y, Kumagai N, Katafuchi-Nagashima M, Sugiura K, Pillai R, Tatsumi Y.
Antimicrob Agents Chemother · brief-report; journal article · DOI 10.1128/aac.02703-13Efinaconazole (Jublia) for the treatment of onychomycosis.
Gupta AK, Simpson FC.
Expert Rev Anti Infect Ther · journal article · DOI 10.1586/14787210.2014.919852Efinaconazole 10% nail solution: a new topical treatment with broad antifungal activity for onychomycosis monotherapy.
Gupta AK, Paquet M.
J Cutan Med Surg · research support, non-u.s. gov't; review; journal article · DOI 10.2310/7750.2013.13095The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
Sugiura K, Sugimoto N, Hosaka S, Katafuchi-Nagashima M, Arakawa Y, Tatsumi Y, Jo Siu W, Pillai R.
Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00111-14An enantioselective synthesis of the key intermediate for triazole antifungal agents; application to the catalytic asymmetric synthesis of efinaconazole (Jublia).
Tamura K, Kumagai N, Shibasaki M.
J Org Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jo500369yTopical treatment of onychomycosis as a realistic option to systemic therapy: a case report.
Gupta AK.
J Am Podiatr Med Assoc · research support, non-u.s. gov't; journal article; case reports · DOI 10.7547/0003-0538-104.1.115Efinaconazole: a new topical treatment for onychomycosis.
Gupta AK, Simpson FC.
Skin Therapy Lett · journal articleEfinaconazole: first global approval.
Patel T, Dhillon S.
Drugs · journal article · DOI 10.1007/s40265-013-0152-xEfinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis.
Tosti A.
Cutis · comparative study; journal articleSafety and pharmacokinetics of efinaconazole 10% solution in healthy volunteers and patients with severe onychomycosis.
Jarratt M, Siu WJ, Yamakawa E, Kodera N, Pillai R, Smith K.
J Drugs Dermatol · clinical trial; multicenter study; journal articleTopical treatment of onychomycosis with efinaconazole solution 10%.
Rich P.
Cutis · research support, non-u.s. gov't; journal article; case reportsCurrent and emerging options in the treatment of onychomycosis.
Elewski B, Pariser D, Rich P, Scher RK.
Semin Cutan Med Surg · research support, non-u.s. gov't; review; journal article · DOI 10.12788/j.sder.0016Mechanism of action of efinaconazole, a novel triazole antifungal agent.
Tatsumi Y, Nagashima M, Shibanushi T, Iwata A, Kangawa Y, Inui F, Siu WJ, Pillai R, Nishiyama Y.
Antimicrob Agents Chemother · brief-report; journal article · DOI 10.1128/aac.02063-12Efinaconazole 10% solution: a new topical treatment for onychomycosis: contact sensitization and skin irritation potential.
Del Rosso JQ, Reece B, Smith K, Miller T.
J Clin Aesthet Dermatol · research-article; journal articleEfinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
Tschen EH, Bucko AD, Oizumi N, Kawabata H, Olin JT, Pillai R.
J Drugs Dermatol · clinical trial, phase ii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal articleComparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
Jo Siu WJ, Tatsumi Y, Senda H, Pillai R, Nakamura T, Sone D, Fothergill A.
Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.02056-12Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H, Ieda C, Smith K, Pillai R, Ramakrishna T, Olin JT.
J Am Acad Dermatol · clinical trial, phase ii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.jaad.2012.10.013